img

Global α-adrenoreceptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global α-adrenoreceptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

α-adrenoreceptor antagonists are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
α-adrenoreceptor Antagonists report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global α-adrenoreceptor Antagonists market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hypertension and Raynaud's Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for α-adrenoreceptor Antagonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, α-adrenoreceptor Antagonists key manufacturers include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. Pfizer, Novartis, Merck are top 3 players and held % sales share in total in 2022.
α-adrenoreceptor Antagonists can be divided into Non-selective Antagonists and Selective Antagonists, etc. Non-selective Antagonists is the mainstream product in the market, accounting for % sales share globally in 2022.
α-adrenoreceptor Antagonists is widely used in various fields, such as Hypertension, Raynaud's Disease and Erectile Dysfunction,, etc. Hypertension provides greatest supports to the α-adrenoreceptor Antagonists industry development. In 2022, global % sales of α-adrenoreceptor Antagonists went into Hypertension filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global α-adrenoreceptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Type
Non-selective Antagonists
Selective Antagonists

Segment by Application


Hypertension
Raynaud's Disease
Erectile Dysfunction

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the α-adrenoreceptor Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of α-adrenoreceptor Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the α-adrenoreceptor Antagonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of α-adrenoreceptor Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, α-adrenoreceptor Antagonists introduction, etc. α-adrenoreceptor Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of α-adrenoreceptor Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 α-adrenoreceptor Antagonists Market Overview
1.1 α-adrenoreceptor Antagonists Product Overview
1.2 α-adrenoreceptor Antagonists Market Segment by Type
1.2.1 Non-selective Antagonists
1.2.2 Selective Antagonists
1.3 Global α-adrenoreceptor Antagonists Market Size by Type
1.3.1 Global α-adrenoreceptor Antagonists Market Size Overview by Type (2018-2034)
1.3.2 Global α-adrenoreceptor Antagonists Historic Market Size Review by Type (2018-2024)
1.3.3 Global α-adrenoreceptor Antagonists Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America α-adrenoreceptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.2 Europe α-adrenoreceptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific α-adrenoreceptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.4 Latin America α-adrenoreceptor Antagonists Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa α-adrenoreceptor Antagonists Sales Breakdown by Type (2018-2024)
2 Global α-adrenoreceptor Antagonists Market Competition by Company
2.1 Global Top Players by α-adrenoreceptor Antagonists Sales (2018-2024)
2.2 Global Top Players by α-adrenoreceptor Antagonists Revenue (2018-2024)
2.3 Global Top Players by α-adrenoreceptor Antagonists Price (2018-2024)
2.4 Global Top Manufacturers α-adrenoreceptor Antagonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 α-adrenoreceptor Antagonists Market Competitive Situation and Trends
2.5.1 α-adrenoreceptor Antagonists Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by α-adrenoreceptor Antagonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in α-adrenoreceptor Antagonists as of 2022)
2.7 Date of Key Manufacturers Enter into α-adrenoreceptor Antagonists Market
2.8 Key Manufacturers α-adrenoreceptor Antagonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 α-adrenoreceptor Antagonists Status and Outlook by Region
3.1 Global α-adrenoreceptor Antagonists Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global α-adrenoreceptor Antagonists Historic Market Size by Region
3.2.1 Global α-adrenoreceptor Antagonists Sales in Volume by Region (2018-2024)
3.2.2 Global α-adrenoreceptor Antagonists Sales in Value by Region (2018-2024)
3.2.3 Global α-adrenoreceptor Antagonists Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global α-adrenoreceptor Antagonists Forecasted Market Size by Region
3.3.1 Global α-adrenoreceptor Antagonists Sales in Volume by Region (2024-2034)
3.3.2 Global α-adrenoreceptor Antagonists Sales in Value by Region (2024-2034)
3.3.3 Global α-adrenoreceptor Antagonists Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global α-adrenoreceptor Antagonists by Application
4.1 α-adrenoreceptor Antagonists Market Segment by Application
4.1.1 Hypertension
4.1.2 Raynaud's Disease
4.1.3 Erectile Dysfunction
4.2 Global α-adrenoreceptor Antagonists Market Size by Application
4.2.1 Global α-adrenoreceptor Antagonists Market Size Overview by Application (2018-2034)
4.2.2 Global α-adrenoreceptor Antagonists Historic Market Size Review by Application (2018-2024)
4.2.3 Global α-adrenoreceptor Antagonists Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America α-adrenoreceptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.2 Europe α-adrenoreceptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific α-adrenoreceptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.4 Latin America α-adrenoreceptor Antagonists Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa α-adrenoreceptor Antagonists Sales Breakdown by Application (2018-2024)
5 North America α-adrenoreceptor Antagonists by Country
5.1 North America α-adrenoreceptor Antagonists Historic Market Size by Country
5.1.1 North America α-adrenoreceptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America α-adrenoreceptor Antagonists Sales in Volume by Country (2018-2024)
5.1.3 North America α-adrenoreceptor Antagonists Sales in Value by Country (2018-2024)
5.2 North America α-adrenoreceptor Antagonists Forecasted Market Size by Country
5.2.1 North America α-adrenoreceptor Antagonists Sales in Volume by Country (2024-2034)
5.2.2 North America α-adrenoreceptor Antagonists Sales in Value by Country (2024-2034)
6 Europe α-adrenoreceptor Antagonists by Country
6.1 Europe α-adrenoreceptor Antagonists Historic Market Size by Country
6.1.1 Europe α-adrenoreceptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe α-adrenoreceptor Antagonists Sales in Volume by Country (2018-2024)
6.1.3 Europe α-adrenoreceptor Antagonists Sales in Value by Country (2018-2024)
6.2 Europe α-adrenoreceptor Antagonists Forecasted Market Size by Country
6.2.1 Europe α-adrenoreceptor Antagonists Sales in Volume by Country (2024-2034)
6.2.2 Europe α-adrenoreceptor Antagonists Sales in Value by Country (2024-2034)
7 Asia-Pacific α-adrenoreceptor Antagonists by Region
7.1 Asia-Pacific α-adrenoreceptor Antagonists Historic Market Size by Region
7.1.1 Asia-Pacific α-adrenoreceptor Antagonists Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific α-adrenoreceptor Antagonists Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific α-adrenoreceptor Antagonists Sales in Value by Region (2018-2024)
7.2 Asia-Pacific α-adrenoreceptor Antagonists Forecasted Market Size by Region
7.2.1 Asia-Pacific α-adrenoreceptor Antagonists Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific α-adrenoreceptor Antagonists Sales in Value by Region (2024-2034)
8 Latin America α-adrenoreceptor Antagonists by Country
8.1 Latin America α-adrenoreceptor Antagonists Historic Market Size by Country
8.1.1 Latin America α-adrenoreceptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America α-adrenoreceptor Antagonists Sales in Volume by Country (2018-2024)
8.1.3 Latin America α-adrenoreceptor Antagonists Sales in Value by Country (2018-2024)
8.2 Latin America α-adrenoreceptor Antagonists Forecasted Market Size by Country
8.2.1 Latin America α-adrenoreceptor Antagonists Sales in Volume by Country (2024-2034)
8.2.2 Latin America α-adrenoreceptor Antagonists Sales in Value by Country (2024-2034)
9 Middle East and Africa α-adrenoreceptor Antagonists by Country
9.1 Middle East and Africa α-adrenoreceptor Antagonists Historic Market Size by Country
9.1.1 Middle East and Africa α-adrenoreceptor Antagonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa α-adrenoreceptor Antagonists Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa α-adrenoreceptor Antagonists Sales in Value by Country (2018-2024)
9.2 Middle East and Africa α-adrenoreceptor Antagonists Forecasted Market Size by Country
9.2.1 Middle East and Africa α-adrenoreceptor Antagonists Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa α-adrenoreceptor Antagonists Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer α-adrenoreceptor Antagonists Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis α-adrenoreceptor Antagonists Products Offered
10.2.5 Novartis Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck α-adrenoreceptor Antagonists Products Offered
10.3.5 Merck Recent Development
10.4 Astra Zeneca
10.4.1 Astra Zeneca Company Information
10.4.2 Astra Zeneca Introduction and Business Overview
10.4.3 Astra Zeneca α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Astra Zeneca α-adrenoreceptor Antagonists Products Offered
10.4.5 Astra Zeneca Recent Development
10.5 Jhonson and Johnson
10.5.1 Jhonson and Johnson Company Information
10.5.2 Jhonson and Johnson Introduction and Business Overview
10.5.3 Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Jhonson and Johnson α-adrenoreceptor Antagonists Products Offered
10.5.5 Jhonson and Johnson Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly α-adrenoreceptor Antagonists Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi α-adrenoreceptor Antagonists Products Offered
10.7.5 Sanofi Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb α-adrenoreceptor Antagonists Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bayer α-adrenoreceptor Antagonists Products Offered
10.9.5 Bayer Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.10.4 GSK α-adrenoreceptor Antagonists Products Offered
10.10.5 GSK Recent Development
10.11 Teva Pharmaceutical
10.11.1 Teva Pharmaceutical Company Information
10.11.2 Teva Pharmaceutical Introduction and Business Overview
10.11.3 Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Teva Pharmaceutical α-adrenoreceptor Antagonists Products Offered
10.11.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 α-adrenoreceptor Antagonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 α-adrenoreceptor Antagonists Industrial Chain Analysis
11.4 α-adrenoreceptor Antagonists Market Dynamics
11.4.1 α-adrenoreceptor Antagonists Industry Trends
11.4.2 α-adrenoreceptor Antagonists Market Drivers
11.4.3 α-adrenoreceptor Antagonists Market Challenges
11.4.4 α-adrenoreceptor Antagonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 α-adrenoreceptor Antagonists Distributors
12.3 α-adrenoreceptor Antagonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-selective Antagonists
Table 2. Major Company of Selective Antagonists
Table 3. Global α-adrenoreceptor Antagonists Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (K MT)
Table 5. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Type (2018-2024)
Table 6. Global α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US& Million)
Table 7. Global α-adrenoreceptor Antagonists Market Share in Value by Type (2018-2024)
Table 8. Global α-adrenoreceptor Antagonists Price by Type (2018-2024) & (USD/MT)
Table 9. Global α-adrenoreceptor Antagonists Sales by Type (2024-2034) & (K MT)
Table 10. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Type (2024-2034)
Table 11. Global α-adrenoreceptor Antagonists Sales by Type (2024-2034) & (US$ Million)
Table 12. Global α-adrenoreceptor Antagonists Sales Market Share in Value by Type (2024-2034)
Table 13. Global α-adrenoreceptor Antagonists Price by Type (2024-2034) & (USD/MT)
Table 14. North America α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (K MT)
Table 15. North America α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe α-adrenoreceptor Antagonists Sales (K MT) by Type (2018-2024)
Table 17. Europe α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific α-adrenoreceptor Antagonists Sales (K MT) by Type (2018-2024)
Table 19. Asia-Pacific α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America α-adrenoreceptor Antagonists Sales (K MT) by Type (2018-2024)
Table 21. Latin America α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa α-adrenoreceptor Antagonists Sales (K MT) by Type (2018-2024)
Table 23. Middle East and Africa α-adrenoreceptor Antagonists Sales by Type (2018-2024) & (US$ Million)
Table 24. Global α-adrenoreceptor Antagonists Sales by Company (2018-2024) & (K MT)
Table 25. Global α-adrenoreceptor Antagonists Sales Share by Company (2018-2024)
Table 26. Global α-adrenoreceptor Antagonists Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global α-adrenoreceptor Antagonists Revenue Share by Company (2018-2024)
Table 28. Global Market α-adrenoreceptor Antagonists Price by Company (2018-2024) & (USD/MT)
Table 29. Global α-adrenoreceptor Antagonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global α-adrenoreceptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in α-adrenoreceptor Antagonists as of 2022)
Table 32. Date of Key Manufacturers Enter into α-adrenoreceptor Antagonists Market
Table 33. Key Manufacturers α-adrenoreceptor Antagonists Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global α-adrenoreceptor Antagonists Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global α-adrenoreceptor Antagonists Sales by Region (2018-2024) & (K MT)
Table 37. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 38. Global α-adrenoreceptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 39. Global α-adrenoreceptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 40. Global α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global α-adrenoreceptor Antagonists Sales by Region (2024-2034) & (K MT)
Table 42. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 43. Global α-adrenoreceptor Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 44. Global α-adrenoreceptor Antagonists Sales Market Share in Value by Region (2024-2034)
Table 45. Global α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global α-adrenoreceptor Antagonists Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (K MT)
Table 48. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Application (2018-2024)
Table 49. Global α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 50. Global α-adrenoreceptor Antagonists Sales Market Share in Value by Application (2018-2024)
Table 51. Global α-adrenoreceptor Antagonists Price by Application (2018-2024) & (USD/MT)
Table 52. Global α-adrenoreceptor Antagonists Sales by Application (2024-2034) & (K MT)
Table 53. Global α-adrenoreceptor Antagonists Sales Market Share in Volume by Application (2024-2034)
Table 54. Global α-adrenoreceptor Antagonists Sales by Application (2024-2034) & (US$ Million)
Table 55. Global α-adrenoreceptor Antagonists Sales Market Share in Value by Application (2024-2034)
Table 56. Global α-adrenoreceptor Antagonists Price by Application (2024-2034) & (USD/MT)
Table 57. North America α-adrenoreceptor Antagonists Sales by Application (2018-2024) (K MT)
Table 58. North America α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe α-adrenoreceptor Antagonists Sales by Application (2018-2024) (K MT)
Table 60. Europe α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific α-adrenoreceptor Antagonists Sales by Application (2018-2024) (K MT)
Table 62. Asia-Pacific α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America α-adrenoreceptor Antagonists Sales by Application (2018-2024) (K MT)
Table 64. Latin America α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa α-adrenoreceptor Antagonists Sales by Application (2018-2024) (K MT)
Table 66. Middle East and Africa α-adrenoreceptor Antagonists Sales by Application (2018-2024) & (US$ Million)
Table 67. North America α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 68. North America α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 69. North America α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 70. North America α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 71. North America α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 72. North America α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 73. North America α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 74. North America α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 75. Europe α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 76. Europe α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 79. Europe α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 80. Europe α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific α-adrenoreceptor Antagonists Sales by Region (2018-2024) & (K MT)
Table 84. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific α-adrenoreceptor Antagonists Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific α-adrenoreceptor Antagonists Sales by Region (2024-2034) & (K MT)
Table 88. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific α-adrenoreceptor Antagonists Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 92. Latin America α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 96. Latin America α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (K MT)
Table 100. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (K MT)
Table 104. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Pfizer α-adrenoreceptor Antagonists Product
Table 111. Pfizer Recent Development
Table 112. Novartis Company Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Novartis α-adrenoreceptor Antagonists Product
Table 116. Novartis Recent Development
Table 117. Merck Company Information
Table 118. Merck Introduction and Business Overview
Table 119. Merck α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Merck α-adrenoreceptor Antagonists Product
Table 121. Merck Recent Development
Table 122. Astra Zeneca Company Information
Table 123. Astra Zeneca Introduction and Business Overview
Table 124. Astra Zeneca α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Astra Zeneca α-adrenoreceptor Antagonists Product
Table 126. Astra Zeneca Recent Development
Table 127. Jhonson and Johnson Company Information
Table 128. Jhonson and Johnson Introduction and Business Overview
Table 129. Jhonson and Johnson α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Jhonson and Johnson α-adrenoreceptor Antagonists Product
Table 131. Jhonson and Johnson Recent Development
Table 132. Eli Lilly Company Information
Table 133. Eli Lilly Introduction and Business Overview
Table 134. Eli Lilly α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Eli Lilly α-adrenoreceptor Antagonists Product
Table 136. Eli Lilly Recent Development
Table 137. Sanofi Company Information
Table 138. Sanofi Introduction and Business Overview
Table 139. Sanofi α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Sanofi α-adrenoreceptor Antagonists Product
Table 141. Sanofi Recent Development
Table 142. Bristol-Myers Squibb Company Information
Table 143. Bristol-Myers Squibb Introduction and Business Overview
Table 144. Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Bristol-Myers Squibb α-adrenoreceptor Antagonists Product
Table 146. Bristol-Myers Squibb Recent Development
Table 147. Bayer Company Information
Table 148. Bayer Introduction and Business Overview
Table 149. Bayer α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Bayer α-adrenoreceptor Antagonists Product
Table 151. Bayer Recent Development
Table 152. GSK Company Information
Table 153. GSK Introduction and Business Overview
Table 154. GSK α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. GSK α-adrenoreceptor Antagonists Product
Table 156. GSK Recent Development
Table 157. Teva Pharmaceutical Company Information
Table 158. Teva Pharmaceutical Introduction and Business Overview
Table 159. Teva Pharmaceutical α-adrenoreceptor Antagonists Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. Teva Pharmaceutical α-adrenoreceptor Antagonists Product
Table 161. Teva Pharmaceutical Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. α-adrenoreceptor Antagonists Market Trends
Table 165. α-adrenoreceptor Antagonists Market Drivers
Table 166. α-adrenoreceptor Antagonists Market Challenges
Table 167. α-adrenoreceptor Antagonists Market Restraints
Table 168. α-adrenoreceptor Antagonists Distributors List
Table 169. α-adrenoreceptor Antagonists Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. α-adrenoreceptor Antagonists Product Picture
Figure 2. Global α-adrenoreceptor Antagonists Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global α-adrenoreceptor Antagonists Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global α-adrenoreceptor Antagonists Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Non-selective Antagonists
Figure 6. Global Non-selective Antagonists Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Selective Antagonists
Figure 8. Global Selective Antagonists Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Global α-adrenoreceptor Antagonists Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global α-adrenoreceptor Antagonists Sales Market Share by Type in 2022 & 2034
Figure 11. North America α-adrenoreceptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 12. North America α-adrenoreceptor Antagonists Sales Market Share in Value by Type in 2022
Figure 13. Europe α-adrenoreceptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 14. Europe α-adrenoreceptor Antagonists Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Value by Type in 2022
Figure 17. Latin America α-adrenoreceptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 18. Latin America α-adrenoreceptor Antagonists Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by α-adrenoreceptor Antagonists Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by α-adrenoreceptor Antagonists Revenue in 2022
Figure 23. α-adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hypertension
Figure 25. Global Hypertension Sales YoY Growth (2018-2034) & (K MT)
Figure 26. Product Picture of Raynaud's Disease
Figure 27. Global Raynaud's Disease Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Erectile Dysfunction
Figure 29. Global Erectile Dysfunction Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Global α-adrenoreceptor Antagonists Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global α-adrenoreceptor Antagonists Sales Market Share by Application in 2022 & 2034
Figure 32. North America α-adrenoreceptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 33. North America α-adrenoreceptor Antagonists Sales Market Share in Value by Application in 2022
Figure 34. Europe α-adrenoreceptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 35. Europe α-adrenoreceptor Antagonists Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share in Value by Application in 2022
Figure 38. Latin America α-adrenoreceptor Antagonists Sales Market Share in Volume by Application in 2022
Figure 39. Latin America α-adrenoreceptor Antagonists Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. α-adrenoreceptor Antagonists Manufacturing Cost Structure
Figure 43. α-adrenoreceptor Antagonists Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries